BBIO
BBIO
NASDAQ · Biotechnology

Bridgebio Pharma Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$74.29
+0.02 (+0.03%)
As of Nov 7, 9:48 PM ET ·
BBIO News3 articles
Alnylam Shares Tumble 28% After Slashing Amvuttra Revenue Forecast
Shares of Alnylam Pharmaceuticals fell 28% after the firm lowered its Amvuttra revenue outlook, erasing $10.9 billion in equity value.
Earnings
Biotech Sector Hit by $15B Loss as Vertex, Ionis Stumble
Vertex and Ionis shares slumped after setbacks, erasing $14.8B in market cap. Crinetics, BridgeBio, and Vera gained $6.1B combined.
Markets
Ionis Plunges 23% After Wainua Misses Key Goal in Heart Disease Trial
Ionis stock tumbled 23% after Wainua missed its primary endpoint in a major heart disease trial, erasing $3.2 billion in market value. The setback shifts attention to the company's TRYNGOLZA launch.
Markets